SALE EXTENDED
MarketBeat All Access
Start your 30-day free trial,
then continue your subscription for 50% off.
TODAY ONLY!
Claim Your Discount
×
S&P 500   3,648.04 (-2.58%)
DOW   29,340.09 (-1.96%)
QQQ   270.15 (-3.44%)
AAPL   140.53 (-3.37%)
MSFT   234.88 (-4.83%)
META   134.46 (-3.31%)
GOOGL   99.04 (-2.35%)
AMZN   114.77 (-4.60%)
TSLA   222.51 (-6.56%)
NVDA   122.30 (-6.85%)
NIO   13.59 (-7.99%)
BABA   81.16 (-3.75%)
AMD   60.37 (-11.02%)
T   15.08 (-1.57%)
MU   53.64 (-1.79%)
CGC   2.99 (-20.27%)
F   12.13 (-1.86%)
GE   64.67 (-2.34%)
DIS   96.91 (-3.13%)
AMC   6.51 (-8.57%)
PYPL   90.38 (-4.28%)
PFE   42.49 (-1.39%)
NFLX   229.70 (-4.30%)
S&P 500   3,648.04 (-2.58%)
DOW   29,340.09 (-1.96%)
QQQ   270.15 (-3.44%)
AAPL   140.53 (-3.37%)
MSFT   234.88 (-4.83%)
META   134.46 (-3.31%)
GOOGL   99.04 (-2.35%)
AMZN   114.77 (-4.60%)
TSLA   222.51 (-6.56%)
NVDA   122.30 (-6.85%)
NIO   13.59 (-7.99%)
BABA   81.16 (-3.75%)
AMD   60.37 (-11.02%)
T   15.08 (-1.57%)
MU   53.64 (-1.79%)
CGC   2.99 (-20.27%)
F   12.13 (-1.86%)
GE   64.67 (-2.34%)
DIS   96.91 (-3.13%)
AMC   6.51 (-8.57%)
PYPL   90.38 (-4.28%)
PFE   42.49 (-1.39%)
NFLX   229.70 (-4.30%)
S&P 500   3,648.04 (-2.58%)
DOW   29,340.09 (-1.96%)
QQQ   270.15 (-3.44%)
AAPL   140.53 (-3.37%)
MSFT   234.88 (-4.83%)
META   134.46 (-3.31%)
GOOGL   99.04 (-2.35%)
AMZN   114.77 (-4.60%)
TSLA   222.51 (-6.56%)
NVDA   122.30 (-6.85%)
NIO   13.59 (-7.99%)
BABA   81.16 (-3.75%)
AMD   60.37 (-11.02%)
T   15.08 (-1.57%)
MU   53.64 (-1.79%)
CGC   2.99 (-20.27%)
F   12.13 (-1.86%)
GE   64.67 (-2.34%)
DIS   96.91 (-3.13%)
AMC   6.51 (-8.57%)
PYPL   90.38 (-4.28%)
PFE   42.49 (-1.39%)
NFLX   229.70 (-4.30%)
S&P 500   3,648.04 (-2.58%)
DOW   29,340.09 (-1.96%)
QQQ   270.15 (-3.44%)
AAPL   140.53 (-3.37%)
MSFT   234.88 (-4.83%)
META   134.46 (-3.31%)
GOOGL   99.04 (-2.35%)
AMZN   114.77 (-4.60%)
TSLA   222.51 (-6.56%)
NVDA   122.30 (-6.85%)
NIO   13.59 (-7.99%)
BABA   81.16 (-3.75%)
AMD   60.37 (-11.02%)
T   15.08 (-1.57%)
MU   53.64 (-1.79%)
CGC   2.99 (-20.27%)
F   12.13 (-1.86%)
GE   64.67 (-2.34%)
DIS   96.91 (-3.13%)
AMC   6.51 (-8.57%)
PYPL   90.38 (-4.28%)
PFE   42.49 (-1.39%)
NFLX   229.70 (-4.30%)
ASX:CSL

CSL - CSL Stock Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
869,289 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
1.12%
Price Target
N/A
CSL stock logo

About CSL (ASX:CSL) Stock

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

Receive CSL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter.

CSL Stock News Headlines

See More Headlines

Receive CSL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter.

CSL Company Calendar

Last Earnings
8/14/2019
Today
10/07/2022

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$10.56 billion
Book Value
A$30.26 per share

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A

Key Executives

  • Mr. Paul R. Perreault B.A. (Age 65)
    MD, CEO & Exec. Director
    Comp: $4.87M
  • Ms. Joy Carolyn Linton B.Com. (Age 57)
    BComm, GAICD, Grad Dip AFI, Chief Financial Officer
    Comp: $2.15M
  • Dr. Paul F. McKenzie Ph.D. (Age 56)
    Chief Operating Officer
    Comp: $2.32M
  • Mr. Mark Dehring
    Head of Investor Relations
  • Mr. Gregory Boss B.S. (Age 61)
    BS(Hons), J.D., Exec. VP of Legal & Group Gen. Counsel
  • Christina Hickie
    Sr. Mang. of Communications
  • Ms. Elizabeth Walker B.A. (Age 52)
    M.S., Exec. VP & Chief HR Officer
  • Dr. Karen Etchberger (Age 64)
    Exec. VP of Quality & Bus. Services
  • Dr. Wilfried Freudenberg
    Department Head of Albumin & Immunoglobulins Production
  • Ms. Jemimah Brennan
    Head of Communications - Asia Pacific













CSL Stock - Frequently Asked Questions

How were CSL's earnings last quarter?

CSL Limited (ASX:CSL) announced its quarterly earnings data on Wednesday, August, 14th. The company reported $4.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.22 by $0.01.

Is CSL a good dividend stock?

CSL (ASX:CSL) pays an annual dividend of A$3.18 per share and currently has a dividend yield of 1.12%. The dividend payout ratio is 43.21%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for CSL.

What other stocks do shareholders of CSL own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CSL investors own include BHP Group (BHP), Commonwealth Bank of Australia (CBA), Cochlear (COH), ResMed (RMD), Telstra (TLS), Woodside Petroleum (WPL), Altium (ALU), Afterpay (APT), Appen (APX) and Berkshire Hathaway (BRK.B).

What is CSL's stock symbol?

CSL trades on the ASX under the ticker symbol "CSL."

How much money does CSL make?

CSL (ASX:CSL) has a market capitalization of $0.00 and generates $10.56 billion in revenue each year.

How many employees does CSL have?

The company employs 25,000 workers across the globe.

How can I contact CSL?

CSL's mailing address is 45 Poplar Road,, Parkville, MELBOURNE, VIC 3052, Australia. The official website for the company is www.csl.com.au. The company can be reached via phone at +61-3-93891911.

This page (ASX:CSL) was last updated on 10/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.